Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GRAIL, Inc. - Common Stock (NQ:GRAL)

63.86 -7.82 (-10.91%)
Streaming Delayed Price Updated: 2:28 PM EDT, Jun 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GRAIL, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Why Grail Shares Crashed Today ↗
The market was disappointed by the more detailed data on a landmark trial for the company's multi-cancer early detection (MCED) test. 
Via The Motley Fool
Topics Death
News headline image
GRAIL’s Galleri Test Cuts Stage 4 Cancer Diagnoses in Study Despite Missed Endpoint ↗
GRAIL (NASDAQ:GRAL) said new data presented at the American Society of Clinical Oncology annual meeting showed its Galleri multi-cancer early detection blood test can identify more cancers through... 
Via MarketBeat
News headline image
Grail's Slump Enters Week 10. Is There Any End in Sight? ↗
Despite a disappointing trial result, there's still a case for buying the stock, with a near-term catalyst on the horizon. 
Via The Motley Fool
News headline image
This Beaten-Down Growth Stock Could Soar 30%, According to Wall Street ↗
Grail's Galleri trial was disappointing, but it isn't down for the count yet. 
Via The Motley Fool
GRAIL INC (NASDAQ:GRAL) Stock Falls After-Hours Despite Q1 Beat and Galleri Test Volume Surge ↗
Via Chartmill
News headline image
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead ↗
GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who... 
Via MarketBeat
News headline image
Here's Why Grail Shares Popped Higher This Week ↗
The company recently reported better-than-expected results, and investors are hoping for more positive news at the end of the month. 
Via The Motley Fool
News headline image
Grail (GRAL) Q1 2026 Earnings Transcript ↗
Grail (GRAL) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Better Healthcare Stock to Own in a Recession: Defensive or Growth? ↗
The answer to the question might surprise many investors. It pays to be open-minded about risk. 
Via The Motley Fool
Topics Economy Energy
News headline image
GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Here's Why Grail Stock Soared Higher This Week ↗
Wall Street continues to warm to the investment proposition for this high-risk and high-reward stock. 
Via The Motley Fool
Topics Earnings
News headline image
This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month ↗
GRAIL, Inc. develops blood-based cancer detection technologies for healthcare providers and individuals seeking early screening solutions. 
Via The Motley Fool
News headline image
Here's Why Grail Shares Crushed the Market This Week ↗
The company's stock received a favorable assessment from a Wall Street analyst this week. 
Via The Motley Fool
News headline image
Here's Why Grail Shares Crashed in February and Why it Could Be a Buying Opportunity ↗
The multi-cancer early detection (MCED) company delivered some extremely bad news to investors in February, but the stock may attract risk tolerant investors now. 
Via The Motley Fool
News headline image
Kaplan Fox Alerts Investors of Grail, Inc. (GRAL) to an Investigation of Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kaplan Fox Alerts Investors of Grail, Inc. (GRAL) to an Investigation of Potential Securities Law Violations
NEW YORK, NY - February 27, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL). 
Via TheNewswire.com
News headline image
Grail, Inc. (NASDAQ: GRAL) Shareholder Investigation - Kaplan Fox Reviewing Potential Claims
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Grail, Inc. (NASDAQ: GRAL) Shareholder Investigation - Kaplan Fox Reviewing Potential Claims
NEW YORK, NY - February 26, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL). 
Via TheNewswire.com
News headline image
Grail, Inc. (GRAL) Securities Investigation Announced by Kaplan Fox & Kilsheimer LLP
NEW YORK, NY - February 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL). 
Via TheNewswire.com
News headline image
Grail, Inc. (GRAL) Securities Investigation Announced by Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Here's Why Grail Stock Bounced Back 16% Today ↗
The market took a more positive view on the company's prospects today, and there's still an opportunity, however small, for the Galleri trial to prove out. 
Via The Motley Fool
Topics Earnings
News headline image
Grail Investor ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Grail Investor ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law Violations
NEW YORK, NY - February 24, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL). 
Via TheNewswire.com
News headline image
Why Grail Shares Are Plummeting ↗
A large clinical trial of the company's cancer screening test did not produce the desired result. 
Via The Motley Fool
News headline image
GRAL ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law Violations
NEW YORK, NY - February 23, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL). 
Via TheNewswire.com
News headline image
GRAL ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Here's Why Grail Stock Slumped Again Today ↗
The company continues to come under pressure after a very disappointing trial result. 
Via The Motley Fool
News headline image
This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗
GRAIL develops advanced cancer detection technologies, serving healthcare providers and individuals seeking early diagnostic solutions. 
Via The Motley Fool
Topics Regulatory Compliance
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
Here's Why Grail Stock Crashed 50% Today ↗
The top-line results from its landmark trial were not good, but there's more data to come, and it might prove more favorable for investors. 
Via The Motley Fool
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.